Keiko Mizuno

Kagoshima, 8908520, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications

The microRNA Expression Signature of Lung Adenocarcinoma Harboring EGFR Mutations: Identification of Therapeutic Targets for EGFR-TKI Combination Therapy.

The microRNA Expression Signature of Lung Adenocarcinoma Harboring EGFR Mutations: Identification of Therapeutic Targets for EGFR-TKI Combination Therapy.

Journal: International journal of molecular sciences
Published: June 02, 2026

Cold temperature enhances innate eosinophilic airway inflammation via transient receptor potential ankyrin1.

Cold temperature enhances innate eosinophilic airway inflammation via transient receptor potential ankyrin1.

Journal: Frontiers in immunology
Published: June 28, 2025

MicroRNA Signatures in Lung Adenocarcinoma Metastases: Exploring the Oncogenic Targets of Tumor-Suppressive miR-195-5p and miR-195-3p.

MicroRNA Signatures in Lung Adenocarcinoma Metastases: Exploring the Oncogenic Targets of Tumor-Suppressive miR-195-5p and miR-195-3p.

Journal: Cancers
Published: June 11, 2025

Impact of durvalumab re-administration after moderate symptomatic pneumonitis in locally advanced non-small cell lung cancer.

Impact of durvalumab re-administration after moderate symptomatic pneumonitis in locally advanced non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 30, 2025

Platinum plus etoposide with durvalumab for extensive-stage small-cell lung cancer with untreated brain metastases: a multicenter, single-arm phase II trial (LOGiK2001, SPEED).

Platinum plus etoposide with durvalumab for extensive-stage small-cell lung cancer with untreated brain metastases: a multicenter, single-arm phase II trial (LOGiK2001, SPEED).

Journal: ESMO open
Published: March 03, 2025

Sotorasib Is Not Effective in a KRAS-Mutated Patient With Brain Metastases From Lung Adenocarcinoma due to Multiple Gene Co-Mutations.

Sotorasib Is Not Effective in a KRAS-Mutated Patient With Brain Metastases From Lung Adenocarcinoma due to Multiple Gene Co-Mutations.

Journal: Respirology case reports
Published: February 18, 2025

Turtle Study: A Phase 2 Study of Durvalumab Plus Carboplatin and Etoposide in Elderly Patients With Extensive-Stage SCLC (LOGiK 2003).

Turtle Study: A Phase 2 Study of Durvalumab Plus Carboplatin and Etoposide in Elderly Patients With Extensive-Stage SCLC (LOGiK 2003).

Journal: JTO clinical and research reports
Published: December 04, 2024

Identification of Tumor Suppressive miR-144-5p Targets: FAM111B Expression Accelerates the Malignant Phenotypes of Lung Adenocarcinoma.

Identification of Tumor Suppressive miR-144-5p Targets: FAM111B Expression Accelerates the Malignant Phenotypes of Lung Adenocarcinoma.

Journal: International journal of molecular sciences
Published: August 19, 2024

Therapeutic effects of an ALK inhibitor, brigatinib, on lung large cell neuroendocrine carcinoma with EML4-ALK fusion.

Therapeutic effects of an ALK inhibitor, brigatinib, on lung large cell neuroendocrine carcinoma with EML4-ALK fusion.

Journal: Respiratory investigation
Published: June 07, 2024

Cytomegalovirus cavitary pneumonia in a human immunodeficiency virus-infected patient.

Cytomegalovirus cavitary pneumonia in a human immunodeficiency virus-infected patient.

Journal: Respirology case reports
Published: April 16, 2024

SF6 is a useful expander for post-pneumonectomy syndrome in the long-term course: a case report.

SF6 is a useful expander for post-pneumonectomy syndrome in the long-term course: a case report.

Journal: Surgical case reports
Published: April 10, 2024

A phase II study of weekly carboplatin and concurrent radiotherapy in older adults with locally advanced non-small cell lung cancer (LOGIK1902).

A phase II study of weekly carboplatin and concurrent radiotherapy in older adults with locally advanced non-small cell lung cancer (LOGIK1902).

Journal: Thoracic cancer
Published: March 23, 2024
Showing 1-12 of 65

Last Updated: 09/26/2026